Deinove: dnv3837 antibiotic candidate: the phase ii trial continues in the united states, despite a disrupted context due to the covid-19 outbreak

Regulatory news: deinove (paris:aldei) (euronext growth paris: aldei), a french biotech company that uses its lead generation platform to develop inno

MCRB Ratings Summary

MCRB Quant Ranking